1.

2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.

39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.

absolute neutrophil count (ANC)

absolute reticulocyte count (ARC)
acquired immunodeficiency syndrome
(AIDS)
activated coagulation time (ACT)
activated partial thromboplastin time
(APTT)
partial thromboplastin time (PTT)
activated protein C (APC)
activated protein C resistance (APCR)
acute myocardial infarction (AMI)
adenosine diphosphate (ADP)
adenosine triphosphate (ATP)
antibody (Ab)
anticardiolipin antibody (ACL, ACA)
antihemophilic factor (AHF)
antiphospholipid antibody (APL, APA)
antiphospholipid syndrome (APS)
antithrombin (AT)
aspirin (acetylsalicylic acid, ASA)
atrial fibrillation (AFIB)
band neutrophil (band)
basophil (baso)
Bernard-Soulier syndrome (BSS)
b2-glycoprotein I (2-GPI)
b-thromboglobulin (-TG)
2,3-bisphosphoglycerate (2,3-BPG)
2,3-diphosphoglycerate (2,3-DPG)
bleeding time (BT)
burst-forming unit (BFU)
cellular immunity (cell-mediated
immunity, CMI)
cerebrospinal fluid (CSF)
cerebrovascular accident (CVA)
Clinical and Laboratory Standards
Institute (CLSI)
Clinical and Laboratory Improvement
Amendments (CLIA)
cluster of differentiation (CD)
coefficient of variation (CV)
percent CV (CV%)
colony-forming unit (CFU)
colony-forming unitgranulocyte,
erythrocyte, monocyte, and
megakaryocyte (CFU-GEMM)
colony-stimulating factor (CSF)
complement (C)
confidence interval (CI)
Coombs test (direct antiglobulin test,
DAT)
coronary artery bypass grafting (CABG)
cryoprecipitate (CRYO)
cytomegalovirus (CMV)
D-dimer (D:D, D-D)
deep vein thrombosis (DVT, deep venous
thrombosis)
11-dehydrothromboxane B2 (11-DHT)
dense granule (dense body, -body, granule)
deoxyribonucleic acid (DNA)
Diamond-Blackfan anemia (DBA,
congenital pure red cell aplasia)
dilute Russell viper venom time (DRVVT)
direct antiglobulin test (DAT, Coombs
test)
direct thrombin inhibitors (DTIs)

55. disseminated intravascular coagulation

(DIC)
56. Donath-Landsteiner (D-L) autoantibody
57. Embden-Meyerhof pathway (EMP,
glycolysis)
58. endoplasmic reticulum (ER)
59. Epstein-Barr virus (EBV)
60. erythroblastosis fetalis (hemolytic
disease of the fetus and newborn, HDFN)
61. erythrocyte (red blood cell, RBC)
62. erythrocyte sedimentation rate (ESR)
63. erythropoietin (EPO)
64. fibrin degradation products (FDPs)
65. fibrin split products (FSPs)
66. Fitzgerald factor (high-molecular-weight
kininogen, HMWK)
67. Fletcher factor (prekallikrein, PK, pre-K)
68. fluorescence in situ hybridization (FISH)
69. free erythrocyte protoporphyrin (FEP)
70. French-American-British (FAB)
71. fresh frozen plasma (FFP)
72. G banding (GTG banding)
73. Glanzmann thrombasthenia (GT)
74. glucose-6-phosphate dehydrogenase
(G6PD)
75. glycoprotein (GP)
76. graft-versus-host disease (GVHD)
77. GTG banding (G banding)
78. hematocrit (HCT)
79. packed cell volume (PCV)
80. hematopoietic progenitor cell (HPC)
81. hematopoietic stem cell (HSC)
82. hemoglobin (Hb, HGB)
83. hemolytic disease of the fetus and
newborn (HDFN, erythroblastosis fetalis)
84. hemolytic uremic syndrome (HUS)
85. heparin-induced thrombocytopenia with
thrombosis (HIT)
86. hepatitis B virus (HBV)
87. Howell-Jolly (H-J) bodies
88. human leukocyte antigens (HLA)
89. major histocompatibility complex (MHC)
90. immune thrombocytopenic purpura (ITP,
idiopathic thrombocytopenic purpura)
91. autoimmune thrombocytopenic purpura
(AITP)
92. interleukin (IL)
93. international normalized ratio (INR)
94. international reference preparation (IRP)
95. international sensitivity index (ISI)
96. intracranial hemorrhage (ICH,
hemorrhagic stroke)
97. intramuscular (IM)
98. intrinsic factor (IF)
99. lactate dehydrogenase (LD)
100. leukemoid reaction (LR)
101. low-molecular-weight heparin (LMWH)
102. lupus anticoagulant (LA, LAC)
103. major histocompatibility complex (MHC)
104. human leukocyte antigen (HLA)
105. mean cell hemoglobin (MCH)
106. mean cell hemoglobin concentration
(MCHC)
107. mean cell volume (MCV)
108. microangiopathic hemolytic anemia
(MAHA)
109. myelodysplastic syndromes (MDSs)
110. myeloid-to-erythroid (M:E) ratio

111.
112.
113.
114.
115.

myeloperoxidase (MPO)
myeloproliferative neoplasms (MPN)
myeloproliferative disorders (MPD)
non-Hodgkin lymphoma (NHL)
nonsteroidal antiinflammatory drugs
(NSAIDs)
116. nucleated red blood cell (NRBC)
117. nucleus-to-cytoplasm (N:C) ratio
118. numerical aperture (NA)
119. packed cell volume (PCV)
120. hematocrit (HCT)
121. paroxysmal cold hemoglobinuria (PCH)
122. paroxysmal nocturnal hemoglobinuria
(PNH)
123. partial thromboplastin time (PTT)
124. activated partial thromboplastin time
(APTT)
125. percutaneous coronary intervention (PCI)
126. peripheral artery occlusion (PAO)
127. personal protective equipment (PPE)
128. phytohemagglutinin (PHA)
129. plasma frozen within 24 hours (FP24)
130. plasminogen activator inhibitor 1 (PAI-1)
131. platelet factor 4 (PF4)
132. platelet-poor plasma (PPP)
133. platelet-rich plasma (PRP)
134. point-of-care (POC)
135. polycythemia vera (PV)
136. polymerase chain reaction (PCR)
137. polymorphonuclear neutrophil (PMN)
138. segmented neutrophil (seg)
139. prekallikrein (PK, pre-K, Fletcher factor)
140. prostaglandin (PG)
141. protein C (PC)
142. protein S (PS)
143. proteins in vitamin K antagonism
(PIVKA)
144. prothrombin time (protime, PT)
145. pulmonary embolism (PE)
146. pyruvate kinase (PK)
147. Q banding (quinacrine banding)
148. red blood cell (RBC)
149. red cell distribution width (RDW)
150. reference interval (RI)
151. reticulocyte production index (RPI)
152. reticuloendothelial system (RES)
153. reverse transcription polymerase chain
reaction (RT-PCR)
154. Rh immune globulin (RhIg)
155. ribonucleic acid (RNA)
156. segmented neutrophil (seg)
157. polymorphonuclear neutrophil (PMN)
158. subcutaneous (SC)
159. surface-connected canalicular system
(SCCS)
160. open canalicular system (OCS)
161. systemic lupus erythematosus (SLE)
162. thrombin clotting time (TCT)
163. thrombin time (TT)
164. thrombotic thrombocytopenic purpura
(TTP)
165. tissue factor (TF)
166. tissue plasminogen activator (TPA)
167. unfractionated heparin (UFH, standard
heparin)
168. vitamin K antagonist (VKA)